Comparison of clinical features and liver histology in hepatitis C- positive dialysis patients and renal transplant recipients

Daniel Glicklich, Swan N. Thung, Toros Kapoian, Vivian Tellis, John F. Reinus

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

Objective: Liver biopsies in hepatitis C virus (HCV)positive end stage renal disease (ESRD) patients before or after renal transplantation were compared to study the effect of transplant-related immunosuppression. Methods: In this prospective study all patients on the active transplant list and all patients with functioning renal transplants at our hospital were tested for HCV antibody (ELISA-2) over a 30-month period. HCV infection was confirmed by polymerase chain reaction in most patients. All HCV-positive patients were asked to undergo liver biopsy without regard to serum transaminase levels. Patients were interviewed, examined, and had detailed chart review. By protocol, liver histology was evaluated according to stage and inflammatory activity in a blinded fashion. Results: There were 129 HCV- antibody-positive patients, of 795 tested. Sixty-seven agreed to liver biopsy. Of these, 22 patients had never been transplanted and 45 had received transplants. Mean transplant duration before biopsy was 41.2 months (range, 1-204 months). Transplant patients had significantly longer duration of ESRD and estimated duration of HCV infection than patients not transplanted. Dialysis patients had significantly more portal inflammatory activity and lymphoid follicles on biopsy whereas transplant patients had more piecemeal necrosis and steatosis. However, the total histological activity score and stage were similar between groups. Multivariate analysis confirmed the association between transplant and steatosis. But independent variables including transplant duration, HCV infection duration, and ESRD duration were not correlated with histological findings. Conclusion: Renal transplantation may not be associated with an increased risk of progressive liver disease in HCV-positive patients, compared with ESRD patients receiving chronic dialysis. Long-term studies with serial liver biopsies are needed to resolve this issue.

Original languageEnglish (US)
Pages (from-to)159-163
Number of pages5
JournalAmerican Journal of Gastroenterology
Volume94
Issue number1
DOIs
StatePublished - Jan 1999

Fingerprint

Hepatitis C
Renal Dialysis
Histology
Liver
Transplants
Hepacivirus
Biopsy
Chronic Kidney Failure
Virus Diseases
Hepatitis C Antibodies
Transplant Recipients
Kidney Transplantation
Dialysis
Transaminases
Immunosuppression
Liver Diseases
Necrosis
Multivariate Analysis
Enzyme-Linked Immunosorbent Assay

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Comparison of clinical features and liver histology in hepatitis C- positive dialysis patients and renal transplant recipients. / Glicklich, Daniel; Thung, Swan N.; Kapoian, Toros; Tellis, Vivian; Reinus, John F.

In: American Journal of Gastroenterology, Vol. 94, No. 1, 01.1999, p. 159-163.

Research output: Contribution to journalArticle

@article{d1ff17acdc4447e5a989b7a0baca30b1,
title = "Comparison of clinical features and liver histology in hepatitis C- positive dialysis patients and renal transplant recipients",
abstract = "Objective: Liver biopsies in hepatitis C virus (HCV)positive end stage renal disease (ESRD) patients before or after renal transplantation were compared to study the effect of transplant-related immunosuppression. Methods: In this prospective study all patients on the active transplant list and all patients with functioning renal transplants at our hospital were tested for HCV antibody (ELISA-2) over a 30-month period. HCV infection was confirmed by polymerase chain reaction in most patients. All HCV-positive patients were asked to undergo liver biopsy without regard to serum transaminase levels. Patients were interviewed, examined, and had detailed chart review. By protocol, liver histology was evaluated according to stage and inflammatory activity in a blinded fashion. Results: There were 129 HCV- antibody-positive patients, of 795 tested. Sixty-seven agreed to liver biopsy. Of these, 22 patients had never been transplanted and 45 had received transplants. Mean transplant duration before biopsy was 41.2 months (range, 1-204 months). Transplant patients had significantly longer duration of ESRD and estimated duration of HCV infection than patients not transplanted. Dialysis patients had significantly more portal inflammatory activity and lymphoid follicles on biopsy whereas transplant patients had more piecemeal necrosis and steatosis. However, the total histological activity score and stage were similar between groups. Multivariate analysis confirmed the association between transplant and steatosis. But independent variables including transplant duration, HCV infection duration, and ESRD duration were not correlated with histological findings. Conclusion: Renal transplantation may not be associated with an increased risk of progressive liver disease in HCV-positive patients, compared with ESRD patients receiving chronic dialysis. Long-term studies with serial liver biopsies are needed to resolve this issue.",
author = "Daniel Glicklich and Thung, {Swan N.} and Toros Kapoian and Vivian Tellis and Reinus, {John F.}",
year = "1999",
month = "1",
doi = "10.1111/j.1572-0241.1999.00788.x",
language = "English (US)",
volume = "94",
pages = "159--163",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Comparison of clinical features and liver histology in hepatitis C- positive dialysis patients and renal transplant recipients

AU - Glicklich, Daniel

AU - Thung, Swan N.

AU - Kapoian, Toros

AU - Tellis, Vivian

AU - Reinus, John F.

PY - 1999/1

Y1 - 1999/1

N2 - Objective: Liver biopsies in hepatitis C virus (HCV)positive end stage renal disease (ESRD) patients before or after renal transplantation were compared to study the effect of transplant-related immunosuppression. Methods: In this prospective study all patients on the active transplant list and all patients with functioning renal transplants at our hospital were tested for HCV antibody (ELISA-2) over a 30-month period. HCV infection was confirmed by polymerase chain reaction in most patients. All HCV-positive patients were asked to undergo liver biopsy without regard to serum transaminase levels. Patients were interviewed, examined, and had detailed chart review. By protocol, liver histology was evaluated according to stage and inflammatory activity in a blinded fashion. Results: There were 129 HCV- antibody-positive patients, of 795 tested. Sixty-seven agreed to liver biopsy. Of these, 22 patients had never been transplanted and 45 had received transplants. Mean transplant duration before biopsy was 41.2 months (range, 1-204 months). Transplant patients had significantly longer duration of ESRD and estimated duration of HCV infection than patients not transplanted. Dialysis patients had significantly more portal inflammatory activity and lymphoid follicles on biopsy whereas transplant patients had more piecemeal necrosis and steatosis. However, the total histological activity score and stage were similar between groups. Multivariate analysis confirmed the association between transplant and steatosis. But independent variables including transplant duration, HCV infection duration, and ESRD duration were not correlated with histological findings. Conclusion: Renal transplantation may not be associated with an increased risk of progressive liver disease in HCV-positive patients, compared with ESRD patients receiving chronic dialysis. Long-term studies with serial liver biopsies are needed to resolve this issue.

AB - Objective: Liver biopsies in hepatitis C virus (HCV)positive end stage renal disease (ESRD) patients before or after renal transplantation were compared to study the effect of transplant-related immunosuppression. Methods: In this prospective study all patients on the active transplant list and all patients with functioning renal transplants at our hospital were tested for HCV antibody (ELISA-2) over a 30-month period. HCV infection was confirmed by polymerase chain reaction in most patients. All HCV-positive patients were asked to undergo liver biopsy without regard to serum transaminase levels. Patients were interviewed, examined, and had detailed chart review. By protocol, liver histology was evaluated according to stage and inflammatory activity in a blinded fashion. Results: There were 129 HCV- antibody-positive patients, of 795 tested. Sixty-seven agreed to liver biopsy. Of these, 22 patients had never been transplanted and 45 had received transplants. Mean transplant duration before biopsy was 41.2 months (range, 1-204 months). Transplant patients had significantly longer duration of ESRD and estimated duration of HCV infection than patients not transplanted. Dialysis patients had significantly more portal inflammatory activity and lymphoid follicles on biopsy whereas transplant patients had more piecemeal necrosis and steatosis. However, the total histological activity score and stage were similar between groups. Multivariate analysis confirmed the association between transplant and steatosis. But independent variables including transplant duration, HCV infection duration, and ESRD duration were not correlated with histological findings. Conclusion: Renal transplantation may not be associated with an increased risk of progressive liver disease in HCV-positive patients, compared with ESRD patients receiving chronic dialysis. Long-term studies with serial liver biopsies are needed to resolve this issue.

UR - http://www.scopus.com/inward/record.url?scp=0032919671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032919671&partnerID=8YFLogxK

U2 - 10.1111/j.1572-0241.1999.00788.x

DO - 10.1111/j.1572-0241.1999.00788.x

M3 - Article

C2 - 9934748

AN - SCOPUS:0032919671

VL - 94

SP - 159

EP - 163

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 1

ER -